FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to an anti-BK virus antibody molecule, or a fragment thereof, which binds the BK virus.
EFFECT: invention is effective for use in treating or preventing infection with BK virus and/or BK virus-associated disorders.
5 cl, 8 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-SIGLEC-9 ANTIBODY MOLECULES | 2020 |
|
RU2833330C1 |
| IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS | 2019 |
|
RU2828590C2 |
| IMPROVED ANTI-FLT3 ANTIGEN-BINDING PROTEINS | 2019 |
|
RU2830982C2 |
| METHOD FOR REDUCING ERRONEOUS INCLUSION OF NON-CANONICAL BRANCHED-CHAIN AMINO ACIDS | 2019 |
|
RU2816654C2 |
| BISPECIFIC ANTIBODY AGAINST RABIES VIRUS AND ITS APPLICATION | 2019 |
|
RU2764740C1 |
| HUMAN CYTOMEGALOVIRUS ANTIBODY AND USE THEREOF | 2020 |
|
RU2817217C1 |
| NEW FISH CORONAVIRUS | 2020 |
|
RU2813731C2 |
| TRISPECIFIC BINDING MOLECULES FOR TREATING VIRAL HEPATITIS B INFECTION AND BOUND STATES | 2016 |
|
RU2733496C2 |
| COMBINATION THERAPY USING ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER TREATMENT | 2014 |
|
RU2792932C2 |
| T-CELL RECEPTOR CONSTRUCTS AND THEIR USE | 2019 |
|
RU2785954C2 |
